PPI Lawsuits are still awaiting...

Introduction

As the PPI case filings seem to have significantly increased, the Judicial Panel on Multidistrict Litigation (JPML) took a decision to hear the argument of PPI litigations on July 27, 2017, under a new motion to create centralization of cases under MDL, which was earlier rejected by U.S. District Judge Sarah Vance as the cases seemed too complicated with so many generics and manufacturers connected with PPIs. This hearing may bring out a positive turn to PPI litigation.

Comments

Walgreens Settles Federal Opioid Case for $300 Million

Categories: Opioids

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.

The U.S. Department of Justice announced on Monday…

Study: Opioid Use in Pregnancy May Shrink Newborn Brains

Categories: Opioids

New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…

Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting

Categories: Opioids

The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…

PPI Lawsuits are still awaiting...